The use of sildenafil to treat portopulmonary hypertension prior to liver transplantation

Annals of Hepatology

Volumn 8, Issue 2, 2009, Pages 158-161

  Cadden, Ian S H ^a   Greanya, Erica D ^a,b   Erb, Siegfried R ^c   Scudamore, Charles H ^a,d   Yoshida, Eric M ^c,d  

^a Department of Gastroenterology ^*

^b ALTNAGELVIN HOSPITAL   (United Kingdom)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cirrhosis; Liver transplantation; Portopulmonary; Pulmonary hypertension; Sildenafil

Indexed keywords

SILDENAFIL;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HEPATITIS C; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; LUNG ARTERY PRESSURE; MALE; PORTOPULMONARY HYPERTENSION;

EID: 67650555952     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31798-3     Document Type: Article

References (24)

1. Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 2003; 361: 1533-1544
2. Strange JW, Wharton J, Phillips PG, Wilkins MR. Recent insights into the pathogenesis and therapeutics of pulmonary hypertension. Clin Sci 2002; 102: 253-268 (Pubitemid 34214388)
3. Lebrec D, Capron JP, Dhumeaux D, Benhamou JP. Pulmonary hypertension complicating portal hypertension. Am Rev Respir Dis 1979; 120: 849-856
4. McDonnell PJ, Toye PA, Hutchins GM. Primary pulmonary hypertension and cirrhosis: are they related? Am Rev Respir Dis 1983; 127: 437-441
5. Hadengue A, Benhayou MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology 1991; 100: 520-528
6. Yang YY, Lin HC, Lee WC, Hou MC, Lee FY, Chang FY, et al. Portopulmonary hypertension: distinctive hemodynamic and clinical manifestations. J Gastroenterol 2001; 36: 181-186 (Pubitemid 32285076)
7. Michael AE, Ramsay B, Simpson R, Nguyen AT, Ramsay KG, East C, et al. Severe pulmonary hypertension in liver transplant candidates. Liver Transplant Surg 1997; 3: 494-500. (Pubitemid 27427898)
8. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonary- related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000; 6: 443-450. (Pubitemid 30489117)
9. Castro M, Krowka MJ, Schroeder DR, Beck KC, Plevak DJ, Rettke SR, et al. Frequency and clinical implications of increased pulmonary pressure in liver transplant patients. Mayo Clin Proc 1996; 71: 543-551 (Pubitemid 126765391)
10. Herve P, Lebrec D, Brenot F, Simonneau G, Humbert M, Sitbon O, et al. Pulmonary vascular disorder in portal hypertension. Eur Respir J 1998; 11: 1153-1166 (Pubitemid 28281039)
11. Robalino BD, Moodie DS. Association between primary pulmonary hypertension and portal hypertension: analysis of its clinical, laboratory and hemodynamic manifestations. J Am Coll Cardiol 1991; 17: 492-498
12. Halank M, Ewert R, Seyfarth HJ, Hoeffken G. Portopulmonary hypertension. J Gastroenterol 2006; 41: 837-847.
13. McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, Fortin TA et al. Screening, early detection and diagnosis of pulmonary arterial hypertension. Chest 2004; 126: 14S-34S.
14. Colle IO, Moreau R, Godinho E, Belghiti J, Ettori F, Cohen-Solal A et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation : a prospective study. Hepatology 2003; 37: 401-409 (Pubitemid 36152540)
15. Csete M. Intraoperative management of liver transplant patients with pulmonary hypertension. Liver Transpl Surg 1997; 3: 454-455. (Pubitemid 27310192)
16. Mandell MS, Krowka MJ. Formation of a national database on pulmonary hypertension and hepatopulmonary syndrome in chronic liver disease. Anesthesiology 1997; 87: 450-451. (Pubitemid 27435393)
17. Ramsay MA, Simpson BR, Nguyen AT, Ramsay KT, East C, Klintman GB. Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg 1997; 3: 494-500. (Pubitemid 27427898)
18. Mandell MS, Groves BM. Pulmonary hypertension in liver disease. Clin Chest Med 1996; 17: 17-33.
19. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium channel blockers on survival in primary pulmonary hypertension. New Engl J Med 1992; 327: 76-81.
20. Plotkin JS, Kuo PC, Rubin LJ, Gaine S, Howell CD, Laurin J et al. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. Transplantation 1998; 65: 457-459 (Pubitemid 28136484)
21. Krowka MJ, Mandell MS, Ramsay MAE, Kawut SM, Fallon MB, Manzarbeitia C, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transp 2004; 10: 174-182 (Pubitemid 38240114)
22. Wang YW, Lin HC, Yang YY, Hou MC, Lee SD. Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension. J Gastroenterol 2006; 41: 593-597. (Pubitemid 44138202)
23. Schroeder RA, Rafii AA, Plotkin JS, Johnson LB, Rustgi VK, Kuo PC. Use of aerosolized inhaled epoprostenol in the treatment of portopulmonary hypertension. Transplantation 2000; 70: 548-550 (Pubitemid 30641517)
24. Halank M, Marx C, Miehlke S, Hoeffken G. Use of aerosolized inhaled iloprost in the treatment of portopulmonary hypertension. J Gastroenterol 2004; 39: 1222-1223 (Pubitemid 40074294)